DANIEL FRANKE

Daniel Franke stands as a pivotal Principal at M Ventures (Merck), the strategic corporate venture arm of Merck KGaA, Darmstadt, Germany. In this influential position, Mr. Franke plays a crucial role in identifying, evaluating, and nurturing groundbreaking startups that are poised to revolutionize the life science and healthcare landscapes. His work is central to M Ventures' mission of investing in innovative technologies and businesses that align with Merck's strategic interests and commitment to scientific advancement.

At M Ventures, Daniel Franke's investment focus is broad yet deeply specialized, primarily targeting early-stage companies across various high-impact sectors. He actively seeks opportunities in biotechnology, including novel drug discovery platforms, gene therapies, cell therapies, and advanced biologics. Beyond traditional biotech, his expertise extends to digital health solutions, encompassing artificial intelligence in diagnostics, data analytics for personalized medicine, remote patient monitoring, and other disruptive technologies that enhance healthcare delivery and patient outcomes. He also explores investments in innovative medical devices and diagnostics, always with an eye towards scientific rigor and significant market potential.

Mr. Franke's career background is characterized by a strong foundation in both scientific understanding and strategic business development, making him uniquely equipped to navigate the complexities of venture capital in the life sciences. While specific details of his early career are not widely publicized, his current role at M Ventures suggests a history of evaluating complex scientific propositions, understanding market dynamics, and fostering successful partnerships. This blend of scientific acumen and business insight allows him to effectively assess the potential of nascent technologies and guide startups through critical growth phases.

As a Principal, Daniel Franke is deeply involved in the entire investment lifecycle, from initial deal sourcing and due diligence to portfolio management and strategic guidance for invested companies. He works closely with entrepreneurs, leveraging M Ventures' extensive network and resources to help portfolio companies achieve their milestones and accelerate their development. His contributions are vital to building M Ventures' diverse and impactful portfolio, which aims to address unmet medical needs and drive future innovation in healthcare.

Through his dedicated efforts, Daniel Franke embodies M Ventures' commitment to fostering a vibrant ecosystem of innovation. His strategic investments not only promise financial returns but also contribute significantly to the broader scientific community, pushing the boundaries of what is possible in medicine and improving lives globally. He is a key driver in M Ventures' pursuit of transformative technologies that will shape the future of health and science.